Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...
Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...
A 17-year-old white male with Crohn's disease who was receiving maintenance ... Anti-TNF-agent induced psoriasiform skin rash. Management. Discontinuation of anti-TNF therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback